The retailer on Tuesday unveiled a $7B-plus, five-step strategic plan.
The sale to CVS Health, along with a 1.5% comparable store sales decrease, led fourth-quarter sales to decline 4.3% year over year to $20.7 billion.
Investment firm states a split of Unilever’s business and/or cost cutting may also be on the table.
Comprehensive review to be completed in April, when it will communicate further, company states.
Walmart now boasts more than 35 million SKUs online and recently announced free two-day shipping with a minimum $35 order.
Food giant last week bid $143 billion for Unilever.
Unilever declined the initial offer, but it is likely Kraft Heinz will continue to pursue the transaction.
The number of stores to be divested to Fred’s Pharmacy was reportedly a big sticking point, but has now been resolved.
Greenlight Capital’s David Einhorn reportedly initiates position with 1.5 million Fred’s Pharmacy shares and ups Rite Aid stake to nearly 20.5 million shares in the fourth quarter.
Roche, Novartis, Pfizer and Gilead were all named as potential suitors.